News archive search

Search the Newsreel

Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.

Showing
37–72
Matches
812
Sources here
21
Companies here
14
Search results Stored financial headlines

Active search

812 matching headlines

Ticker or company: TELLMain company stories
Clear

Search results

Matching headlines

External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.

Stellantis (BIT:STLAM) Expands Grand Cherokee Lineup, Is The Stock Still Cheap?

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Stellantis (BIT:STLAM) is back in focus after Jeep announced an expanded 2027 Grand Cherokee lineup. The company is adding new Trailhawk, Overland and Upland trims …

STLAN main company STLA main company STLAP main company
Sharemaestro market context Price below Trend Line 52 weeks -51.8% · Next-week setup negative 31.9% STLAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Goldman Sachs Maintains Stellantis NV(STLA.US) With Hold Rating, Cuts Target Price to $6

Goldman Sachs has reiterated its Hold rating on Stellantis NV (STLA.US) but has revised its target price downwards to $6. This adjustment reflects an updated outlook from the investment bank regarding the automotive company's valuation.

STLA main company
Sharemaestro market context Price below Trend Line 52 weeks -47.1% STLA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stellantis (BIT:STLAM) Unveils 2027 Grand Cherokee Overhaul With New Trims And Capability Focus

Get insights on thousands of stocks from the global community of over 7 million individual investors at Simply Wall St. Stellantis (BIT:STLAM) is preparing a major 2027 update to the Jeep Grand Cherokee line, with new trims and expanded off road focused models. The …

STLA main company
Sharemaestro market context Price below Trend Line 52 weeks -47.1% STLA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intellicheck expects GAAP profitability in 2026 as a 29% revenue customer evaluates a multi-vendor IDV approach

Earnings Call Insights: Intellicheck (IDN) Q2 2026 MANAGEMENT VIEW * Bryan Lewis (President, CEO & Director) said the company’s diversification strategy “continues to produce results,” citing “4 consecutive quarters of profitability,” while flagging a customer concentration event: “A customer that represents about 29% of …

IDN main company
Sharemaestro market context Price below Trend Line 52 weeks -47.3% · Next-week setup negative 44.3% IDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stellantis (BIT:STLAM) Stock Looks Reasonable On Value But Weak On Returns

Find winning stocks in any market cycle. Join 7 million investors using Simply Wall St's investing ideas for FREE. Stellantis stock has been under clear pressure in recent years, yet the valuation checks still suggest the shares screen cheap on several measures. That contrast …

STLAN main company STLA main company STLAP main company
Sharemaestro market context Price below Trend Line 52 weeks -51.8% · Next-week setup negative 31.9% STLAN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Constellation Energy Insider Bought Shares Worth $417,931, According to a Recent SEC Filing

An insider at Constellation Energy recently purchased shares valued at $417,931, as reported in a recent SEC filing. This information was published on August 13, 2026, at 05:40 pm EDT. The article is reserved for members only, requiring a login to access the full …

CEG main company
Sharemaestro market context Price above Trend Line 52 weeks -8.5% · Next-week setup positive 58.4% CEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Constellation Energy (CEG) director Roger Crandall purchases 1,500 shares at ~$279

Constellation Energy director Roger W. Crandall purchased 1,500 shares of common stock on August 11, 2026, at a weighted average price of $278.6206 per share. This transaction, not made under a Rule 10b5-1 plan, increased his direct holdings to 1,693 common shares and 462 …

CEG main company
Sharemaestro market context Price above Trend Line 52 weeks -8.5% · Next-week setup positive 58.4% CEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Satellos Q2 loss widens to $11.7M, EPS misses estimates

Satellos Bioscience reported a Q2 2026 net loss of $11.7 million, or $0.56 per share, missing analyst estimates due to significantly increased R&D spending on its Phase 2 DMD clinical trials. Despite the widening loss, the company's cash reserves rose to $61.8 million, providing …

MSLE main company
Sharemaestro market context Stored weekly price path 28 weeks -14.6% MSLE stored weekly price path from 6 Feb 2026 to 14 Aug 2026

Satellos Reports Second Quarter 2026 Financial Results and Highlights Company Progress

Satellos Bioscience Inc. announced its Q2 2026 financial results, reporting a strong cash position of $61.8 million and progress in its clinical trials for SAT-3247, a drug candidate for Duchenne muscular dystrophy (DMD). The company highlighted favorable safety data from the TRAILHEAD adult DMD …

MSLE main company
Sharemaestro market context Stored weekly price path 28 weeks -14.6% MSLE stored weekly price path from 6 Feb 2026 to 14 Aug 2026

Satellos reports stable strength in four-adult Duchenne study

Satellos reported its second quarter 2026 financial results, including a net loss of $11.7 million, and provided updates on its clinical progress for SAT-3247 in Duchenne muscular dystrophy (DMD). The company highlighted stable strength and reduced muscle fat in a Phase 2 adult DMD …

MSLE main company
Sharemaestro market context Stored weekly price path 28 weeks -14.6% MSLE stored weekly price path from 6 Feb 2026 to 14 Aug 2026

Satellos Bioscience (NASDAQ: MSLE) ramps Duchenne R&D and strengthens cash

Satellos Bioscience reported increased net losses in the first half of 2026 due to higher R&D and G&A expenses, driven by advancing its Duchenne muscular dystrophy (DMD) clinical programs, SAT-3247. Despite widening losses, the company significantly strengthened its cash position to $61.8 million through …

MSLE main company
Sharemaestro market context Stored weekly price path 28 weeks -14.6% MSLE stored weekly price path from 6 Feb 2026 to 14 Aug 2026

Earnings call transcript: Intellicheck Q2 2026 revenue edges past forecasts

Intellicheck reported Q2 2026 earnings matching forecasts and revenue slightly above expectations, but the stock dropped 16% after hours due to uncertainty surrounding a major customer's vendor evaluation. Despite strong sequential and year-over-year revenue growth and consistent profitability, investors focused on the potential impact …

IDN main company
Sharemaestro market context Price below Trend Line 52 weeks -47.3% · Next-week setup negative 44.3% IDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Glazer Capital details 7.77% Axiom stake in AXIN Units (AXIN)

Glazer Capital, LLC and Paul J. Glazer have reported a beneficial ownership of 1,600,072 Units in Axiom Intelligence Acquisition Corp 1 (AXIN), representing 7.77% of the outstanding class. The filing specifies that all voting and dispositive power over these securities is shared, with no …

AXIN main company
Sharemaestro market context Trend signal active 52 weeks +3.3% · Next-week setup negative 40.9% AXIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Axiom Intelligence (AXIN) inks Terra Quantum deal amid going concern warning

Axiom Intelligence Acquisition Corp 1 (AXIN) has reported total assets of $208.3 million as of June 30, 2026, and a net income of $2.27 million for the six months ended June 30, 2026, primarily from interest on trust investments. The SPAC has entered into …

AXIN main company
Sharemaestro market context Trend signal active 52 weeks +3.3% · Next-week setup negative 40.9% AXIN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intellicheck (IDN) grows Q2 revenue 16% but flags major customer cutback

Intellicheck (IDN) reported strong Q2 2026 results with a 16% revenue increase to $5.9 million and a return to net income of $663K, driven by higher SaaS transaction volumes. However, the company expects a significant revenue hit in the second half of 2026 due …

IDN main company
Sharemaestro market context Price below Trend Line 52 weeks -47.3% · Next-week setup negative 44.3% IDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intellicheck (IDN) grows Q2 revenue 16% and turns a profit amid customer shift

Intellicheck (IDN) reported strong second-quarter 2026 results with a 16% year-over-year revenue increase to $5.9 million and a net income of $0.7 million, marking its fifth consecutive quarter of positive Adjusted EBITDA. The company also disclosed a significant risk as a major customer, representing …

IDN main company
Sharemaestro market context Price below Trend Line 52 weeks -47.3% · Next-week setup negative 44.3% IDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Constellation Energy (NASDAQ:CEG) Lifts Guidance As Nuclear Demand Grows

Constellation Energy (NASDAQ:CEG) has raised its full-year guidance and secured new long-term power agreements, driven by increasing demand for reliable clean energy, particularly from data centers. The company, a major operator of nuclear generation, is benefiting from renewed interest in nuclear power's ability to …

CEG main company
Sharemaestro market context Price above Trend Line 52 weeks -8.5% · Next-week setup positive 58.4% CEG stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Gilat Presents Expanded Portfolio for Tactical Unmanned Platforms

Gilat Satellite Networks Ltd., through its subsidiary Gilat Defense, has expanded its product portfolio to support tactical unmanned platforms with the introduction of RaySat’s new Viper Ka Electronically Steered Antenna (ESA). The Viper ESA is designed for resilient multi-orbit connectivity across LEO, MEO, and …

GILT main company
Sharemaestro market context Price below Trend Line 52 weeks +22.6% GILT stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Intellicheck Mobilisa, Inc. (IDN) Matches Q2 Earnings Estimates

Intellicheck Mobilisa, Inc. (IDN) reported Q2 earnings of $0.03 per share, meeting the Zacks Consensus Estimate and showing an improvement from a loss of $0.01 per share a year ago. The company's revenues for the quarter were $5.94 million, surpassing estimates. Despite these results, …

IDN main company
Sharemaestro market context Price below Trend Line 52 weeks -47.3% · Next-week setup negative 44.3% IDN stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Stellantis (STLA) explores 93-day supply of Dodge police vehicles as market watches

Stellantis (STLA) is seeing increased market attention due to a surge in U.S. search queries for "Dodge Charger police vehicle prototype," despite no confirmed orders or production timeline. While a return to fleet sales could boost Dodge's visibility, the company's Q2 adjusted operating margin …

STLA main company
Sharemaestro market context Price below Trend Line 52 weeks -47.1% STLA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Wasatch Advisors LP Sells 134,215 Shares of Intellia Therapeutics, Inc. $NTLA

Wasatch Advisors LP significantly reduced its stake in Intellia Therapeutics Inc. by selling 134,215 shares, decreasing its holdings by 51.3%. Despite this, other institutional investors increased their positions in NTLA. The company currently holds a consensus "Hold" rating from analysts with an average price …

NTLA main company
Sharemaestro market context Price below Trend Line 52 weeks +13.2% NTLA stored weekly price path from 22 Aug 2025 to 14 Aug 2026

Find financial news

Search the Newsreel

Use one field or combine several. Results are newest first.

Evidence context